A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Keith M. Channon, Keith G. Oldroyd et al.|International Journal of Cardiology|2021Cited by 16
A Randomised, Double-Blind, Dose Ranging Clinical Trial of Intravenous FDY-5301 in Acute STEMI Patients Undergoing Primary PCI: The CAMPFIRE (CArdiac Muscle Preservation Following Ischemia REperfusion) StudyDavid Adlam, CCC-ACS Investigators, N. Uren et al.|Circulation|2019Cited by 1